992 resultados para 929 Runeberg


Relevância:

10.00% 10.00%

Publicador:

Resumo:

Ilmestyi alunperin 7 vihkona 1905-1906.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Ilmestyi alunperin 7 vihkona 1907-1910

Relevância:

10.00% 10.00%

Publicador:

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Tekijä lopusta: G. E. L.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Tekijä lopusta: A. O. F.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Elias Lönnrot f. 9.4.1802 i Sammatti d. 19.3.1884 i Sammatti Elias Lönnrot är, vid sidan om Mikael Agricola, en av det finska skriftspråkets fäder. Lönnrot är skaparen av Finlands nationalepos Kalevala samt Kanteletar, en samling lyriska dikter. Den standardversion av Kalevala som är i bruk idag, dvs. den nya Kalevala, gavs ut år 1849 i en av Lönnrot bearbetad och redigerad upplaga. I denna upplaga inkluderades också material som hade samlats in av andra än Lönnrot själv. Kanteletar taikka Suomen Kansan Wanhoja Lauluja ja Wirsiä utgavs i tre delar år 1840. Lönnrot gav även ut ordspråk, gåtor och besvärjelsedikter. Han översatte konstpoesi till finska, allt ifrån Homeros till Runeberg och förnyade även finskan som redaktör för flera ordböcker, bland annat en finsk-svensk ordbok. Därtill var han verksam som tidningsman och läkare, samt kunnig inom folkmedicinens område. Hans verk Flora Fennica ger anvisningar om användningen av nyttoväxter och naturläkemedel. http://www.blf.fi/artikel.php?id=2836 http://www.kansallisbiografia.fi/kb/artikkeli/2836/

Relevância:

10.00% 10.00%

Publicador:

Resumo:

We assessed the effect of chronic hyperglycemia on bone mineral density (BMD) and bone remodeling in patients with type 2 diabetes mellitus. We investigated 42 patients with type 2 diabetes under stable control for at least 1 year, 22 of them with good metabolic control (GMC: mean age = 48.8 ± 1.5 years, 11 females) and 20 with poor metabolic control (PMC: mean age = 50.2 ± 1.2 years, 8 females), and 24 normal control individuals (CG: mean age = 46.5 ± 1.1 years, 14 females). We determined BMD in the femoral neck and at the L2-L4 level (DEXA) and serum levels of glucose, total glycated hemoglobin (HbA1), total and ionic calcium, phosphorus, alkaline phosphatase, follicle-stimulating hormone, intact parathyroid hormone (iPTH), 25-hydroxyvitamin D (25-OH-D), insulin-like growth factor I (IGFI), osteocalcin, procollagen type I C propeptide, as well as urinary levels of deoxypyridinoline and creatinine. HbA1 levels were significantly higher in PMC patients (12.5 ± 0.6 vs 7.45 ± 0.2% for GMC and 6.3 ± 0.9% for CG; P < 0.05). There was no difference in 25-OH-D, iPTH or IGFI levels between the three groups. BMD values at L2-L4 (CG = 1.068 ± 0.02 vs GMC = 1.170 ± 0.03 vs PMC = 1.084 ± 0.02 g/cm²) and in the femoral neck (CG = 0.898 ± 0.03 vs GMC = 0.929 ± 0.03 vs PMC = 0.914 ± 0.03 g/cm²) were similar for all groups. PMC presented significantly lower osteocalcin levels than the other two groups, whereas no significant difference in urinary deoxypyridine was observed between groups. The present results demonstrate that hyperglycemia is not associated with increased bone resorption in type 2 diabetes mellitus and that BMD is not altered in type 2 diabetes mellitus.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

The aim of the present study was to compare heart rate variability (HRV) at rest and during exercise using a temporal series obtained with the Polar S810i monitor and a signal from a LYNX® signal conditioner (BIO EMG 1000 model) with a channel configured for the acquisition of ECG signals. Fifteen healthy subjects aged 20.9 ± 1.4 years were analyzed. The subjects remained at rest for 20 min and performed exercise for another 20 min with the workload selected to achieve 60% of submaximal heart rate. RR series were obtained for each individual with a Polar S810i instrument and with an ECG analyzed with a biological signal conditioner. The HRV indices (rMSSD, pNN50, LFnu, HFnu, and LF/HF) were calculated after signal processing and analysis. The unpaired Student t-test and intraclass correlation coefficient were used for data analysis. No statistically significant differences were observed when comparing the values analyzed by means of the two devices for HRV at rest and during exercise. The intraclass correlation coefficient demonstrated satisfactory correlation between the values obtained by the devices at rest (pNN50 = 0.994; rMSSD = 0.995; LFnu = 0.978; HFnu = 0.978; LF/HF = 0.982) and during exercise (pNN50 = 0.869; rMSSD = 0.929; LFnu = 0.973; HFnu = 0.973; LF/HF = 0.942). The calculation of HRV values by means of temporal series obtained from the Polar S810i instrument appears to be as reliable as those obtained by processing the ECG signal captured with a signal conditioner.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Painovuosi nimekkeestä.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Painovuosi nimekkeestä.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Arkit: 1 arkintunnukseton lehti, C-D4 E3.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

We investigated the prognostic effects of high-flux hemodialysis (HFHD) and low-flux hemodialysis (LFHD) in patients with chronic kidney disease (CKD). Both an electronic and a manual search were performed based on our rigorous inclusion and exclusion criteria to retrieve high-quality, relevant clinical studies from various scientific literature databases. Comprehensive meta-analysis 2.0 (CMA 2.0) was used for the quantitative analysis. We initially retrieved 227 studies from the database search. Following a multi-step screening process, eight high-quality studies were selected for our meta-analysis. These eight studies included 4967 patients with CKD (2416 patients in the HFHD group, 2551 patients in the LFHD group). The results of our meta-analysis showed that the all-cause death rate in the HFHD group was significantly lower than that in the LFHD group (OR=0.704, 95%CI=0.533-0.929, P=0.013). Additionally, the cardiovascular death rate in the HFHD group was significantly lower than that in the LFHD group (OR=0.731, 95%CI=0.616-0.866, P<0.001). The results of this meta-analysis clearly showed that HFHD decreases all-cause death and cardiovascular death rates in patients with CKD and that HFHD can therefore be implemented as one of the first therapy choices for CKD.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Julkaisussa Kongl. Vetenskaps Akademiens handlingar Vol. 19, 1758. Beskrifning öfver Lajhela socken i Österbotten / Ephraim Otto Runeberg.